Related Experiment Video

Updated: Jun 12, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K

Eculizumab as rescue therapy in a context of dramatic NMOSD attack: Report of two cases

A San-Galli1, H Chaumont2, Q Bourgeois3

  • 1Department of Neurology, Pierre-Zobda-Quitman University Hospital, 97261 Fort-de-France, Martinique; Faculté de médecine, université des Antilles, Pointe-à-Pitre, Guadeloupe.

Revue Neurologique
|September 24, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.5K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

775

Related Experiment Videos

Last Updated: Jun 12, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.5K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

775

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245

Articles linked to this work by shared authors, journal, and citation graph.

[Neuromyelitis optica spectrum disorder with positive aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibodies].

Journal francais d'ophtalmologie·2026

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Revue neurologique·2025

Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes.

Revue neurologique·2023

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022

Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients.

Revue neurologique·2022

[Control of the transfusion risk in HE: Reflection on the a priori risk approach].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2021

The eyes and Parkinsonian syndromes.

Revue neurologique·2026

Autosomal recessive cerebellar ataxia: What have we learnt in the last 30 years?

Revue neurologique·2026

Trends and regional disparities in triptan dispensing in France between 2014 and 2025: A nationwide open-data study.

Revue neurologique·2026

Access to hospital-based rehabilitation for people with multiple sclerosis in France: A nationwide study (2017-2023).

Revue neurologique·2026

Effect of levodopa-carbidopa intestinal gel infusion on objective measures of daytime sleepiness and nocturnal sleep in Parkinson's disease.

Revue neurologique·2026

Passive digital monitoring via mobile apps and wearables in multiple sclerosis: A systematic review.

Revue neurologique·2026

Integration of light and oxygen signals by archaeal cysteine-less LOV domain.

Journal of photochemistry and photobiology. B, Biology·2026

Photocatalytic Phosphine-mediated Hydroxymethylation of Alkenes With Formaldehyde Hydrate.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026

The Endogenous Metabolite Hypochlorite Activates Indoleamine 2,3-Dioxygenase-1 for Catalysis: Functional and Mechanistic Implications.

Angewandte Chemie (International ed. in English)·2026

RuO2-Based Electrocatalysts for Acidic Oxygen Evolution: Mechanistic Origins of the Activity-Stability Trade-Off and Pathways to Rational Design.

Small (Weinheim an der Bergstrasse, Germany)·2026

A bis(trifluoromethyl)benzenesulfonate-caged red-emissive fluorescent probe for cellular imaging of superoxide anions.

Analytical methods : advancing methods and applications·2026

Photophysics of Doubly Reduced Quinacridone Dyes: Toward Redox Reactivity Activated by Red Light.

Artificial photosynthesis (Washington, D.C.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us